Journal of Scientific Dentistry

Register      Login

VOLUME 7 , ISSUE 1 ( January-December, 2017 ) > List of Articles

CASE REPORT

Idiopathic Thrombocytopenic purpura- A Case Report and an update of recent treatment modalities

Yoga Sivakumar, Vandana S, Kavya L, Dhanraj T

Keywords : Autoimmne, Gingival bleeding, Idiopathic Thrombocytopenic Purpura, Petechiae, platelets

Citation Information : Sivakumar Y, S V, L K, T D. Idiopathic Thrombocytopenic purpura- A Case Report and an update of recent treatment modalities. 2017; 7 (1):24-27.

DOI: 10.5005/jsd-7-1-24

License: CC BY-NC 4.0

Published Online: 01-06-2017

Copyright Statement:  Copyright © 2017; The Author(s).


Abstract

Idiopathic Thrombocytopenic Purpura (ITP) being a hematologic disorder is characterized by reduced count of circulating platelets. The clinical presentation of ITP manifest with petechiae, purpura, gingival bleeding and other manifestations which include Gatrointestinal bleeding, petechial spots over the skin and intracranial hemorrhage in fatal conditions. These may be acute or chronic bleeding with mild to severe symptoms. As a dental professional one must aim at arresting the bleeding from oral cavity and to proceed with further treatment along with physician. Delaying the diagnosis may worsen the condition of ITP. We present a case report on ITP and an update on treatment modalities of ITP.


PDF Share
  1. Kuwana M, Okazaki Y, Satoh T, Asahi A, Kajihara M, Ikeda Y. Initial laboratory findings useful for predicting the diagnosis of idiopathic thrombocytopenic purpura. Am J Med. 2005;118(9):1026-1033.
  2. Terrell DR, Beebe LA, Vesely SK, Neas BR, Segal JB, George JN. The incidence of immune thrombocytopenic purpura in children and adults: a critical review of published reports. Am J Hematol. 2010;85:174-80.
  3. Provan D, Newland A. Fifty years of idiopathic thrombocytopenic purpura management of refractory ITP in adults. Br J Haematol. 2002;118(4):933-44.
  4. Gernsheimer T. Chronic idiopatic thrombocytopenic púrpura: mechanisms of pathogenesis. Oncologist. 2009;14(1):12-21.
  5. . Imbach P, Kuhne T, Muller D, Berchtold W, Zimmerman S, Elalfy M, et al. Childhood ITP: 12 months follow-up data from the prospective registry I of the Intercontinental Childhood ITP Study Group (ICIS). Pediatr Blood Cancer. 2006;46:351-6.
  6. Ver rastro T, Lorenzi FL, Wendel Neto S. Hematologiae hemoterapia: fundamentos de morfologia, fisiologia, patologiae clínica. São Paulo: Atheneu; 2006.
  7. Imbach P, Crowther M. Thrombopoietin receptor agonists for primary immune thrombocytopenia. N Engl J Med. 2011;365:734-41.
  8. Hou M, Peng J, Shi Y, Zhang C, Qin P, Zhao C, et al. Mycophenolate mofetil (MMF) for the treatment of steroidresistant idiopathic thrombocytopenic purpura. Eur J Haematol. 2003;70:353-357.
  9. Damodar S, Viswabandya A, George B, Mathews V, Chandy M, Srivastava A. Dapsone for chronic idiopathic thrombocytopenic purpura in children and adults: a report on 90 patients. Eur J Haematol. 2005;75:328-31.
  10. Elmer P, Cohen R, Garcia CA, Mena D, Castellanos M, Wu L. Case Review: Idiopathic Thrombocytopenic Purpura. 2012;3(2):130
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.